Paul Leufkens, PharmD, MBA, CEO and co-founder
Paul holds MSc and PharmD degrees from Utrecht University and obtained his MBA at Bradford University (UK). Over the past 15 years he has spun out a variety of technologies from University-based research groups. He was a co-founder of AM-Pharma (acquired by Pfizer in 2015), Neurophyxia and Trajectum Pharma, and held senior positions in product development at Exponential Biotherapies Inc. (Washington, DC), Reliance Life Sciences (Mumbai, India) and Pharming (Leiden). Earlier in his career Paul worked in clinical development with Sanofi and Yamanouchi Europe.
Frebus van Slochteren, MSc, PhD, CTO and co-founder
Frebus received his PhD degree in April 2014, defending his thesis entitled “Technical solutions to improve cardiac regenerative therapy”. He is also the inventor (together with Dr. Chamuleau) of the Company’s first patent, filed in April 2014 entitled: “Cardiac imaging processing for interventions” based on the work for his PhD thesis and which is now part of CART-Tech’s core technology. He obtained his MSc degree in Control Systems Engineering from the University of Hertfordshire, and in Medical Engineering of the Eindhoven University of Technology. Per April 2018 Frebus is full-time member of the CART-Tech MT.